Literature DB >> 9353015

Immunogenicity and protective immunity induced by synthetic peptides associated with a catalytic subdomain of mutans group streptococcal glucosyltransferase.

D J Smith1, B Shoushtari, R L Heschel, W F King, M A Taubman.   

Abstract

We examined the immunogenicity and induction of protective immunity of two 19-mer sequences (GGY and AND) which overlapped a highly conserved region which has recently been implicated in the enzymatic activity of glucosyltransferases (GTFs) of the mutans group streptococci. These peptides were synthesized as eight-branched constructs on a lysine core. Serum immunoglobulin G (IgG) antibody, induced by subcutaneous (s.c. [salivary gland vicinity]) injection with these peptide constructs, reacted with the inciting antigen, with mutans streptococcal GTFs, and with a 21-mer peptide (CAT) containing an aspartate previously shown to covalently bind sucrose. Several of these antisera also inhibited the ability of Streptococcus sobrinus GTF to synthesize insoluble glucan. Significant levels of salivary IgA antibody were also induced by GGY and AND peptide constructs after s.c. injection. The effect of immunization with the GGY and AND peptide constructs on the cariogenicity of Streptococcus mutans was studied in three experiments by immunization of weanling Sprague-Dawley rats, twice at 7- to 14-day intervals with peptides, S. sobrinus GTF, or phosphate-buffered saline. All rats were then orally infected with S. mutans SJ. After 63-day infection periods, the GGY and AND-injected groups had significant dental caries reductions compared with sham-injected groups in most experiments. These studies support the existence of an additional catalytic subdomain within the sequence defined by the GGY and AND peptides. Furthermore, the epitopes defined in these sequences have significant immunogenicity, can induce immune responses which interfere with GTF-mediated glucan synthesis in vitro, and can protect rats from experimental dental caries.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353015      PMCID: PMC175636          DOI: 10.1128/iai.65.11.4424-4430.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Nucleotide sequence of a glucosyltransferase gene from Streptococcus sobrinus MFe28.

Authors:  J J Ferretti; M L Gilpin; R R Russell
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

2.  Sequence analysis of the gtfB gene from Streptococcus mutans.

Authors:  T Shiroza; S Ueda; H K Kuramitsu
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

3.  Identification of essential amino acids in the Streptococcus mutans glucosyltransferases.

Authors:  H Tsumori; T Minami; H K Kuramitsu
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

4.  A circularly permuted alpha-amylase-type alpha/beta-barrel structure in glucan-synthesizing glucosyltransferases.

Authors:  E A MacGregor; H M Jespersen; B Svensson
Journal:  FEBS Lett       Date:  1996-01-15       Impact factor: 4.124

5.  Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase.

Authors:  D J Smith; M A Taubman; W F King; S Eida; J R Powell; J Eastcott
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Subsite specificity of the active site of glucosyltransferases from Streptococcus sobrinus.

Authors:  K S Devulapalle; G Mooser
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Effects of local immunization with glucosyltransferase fractions from Streptococcus mutans on dental caries in rats and hamsters.

Authors:  M A Taubman; D J Smith
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Identification of amino acid residues in Streptococcus mutans glucosyltransferases influencing the structure of the glucan product.

Authors:  A Shimamura; Y J Nakano; H Mukasa; H K Kuramitsu
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

9.  Immunologic characteristics of a Streptococcus mutans glucosyltransferase B sucrose-binding site peptide-cholera toxin B-subunit chimeric protein.

Authors:  P Laloi; C L Munro; K R Jones; F L Macrina
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protects against dental caries.

Authors:  M A Taubman; C J Holmberg; D J Smith
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  17 in total

1.  Antibody to glucosyltransferase induced by synthetic peptides associated with catalytic regions of alpha-amylases.

Authors:  D J Smith; R L Heschel; W F King; M A Taubman
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Characterization of salivary immunoglobulin A responses in children heavily exposed to the oral bacterium Streptococcus mutans: influence of specific antigen recognition in infection.

Authors:  Ruchele D Nogueira; Alessandra C Alves; Marcelo H Napimoga; Daniel J Smith; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Human T-cell responses to the glucosyltransferases of Streptococcus mutans.

Authors:  J S Chia; C M You; C Y Hu; B L Chiang; J Y Chen
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

4.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

5.  Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries.

Authors:  M A Taubman; C J Holmberg; D J Smith
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.

Authors:  Ping Zhang; Christina Jespersgaard; Leticia Lamberty-Mallory; Jannet Katz; Yan Huang; George Hajishengallis; Suzanne M Michalek
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Alterations in immunodominance of Streptococcus mutans AgI/II: lessons learned from immunomodulatory antibodies.

Authors:  Rebekah A Robinette; Kyle P Heim; Monika W Oli; Paula J Crowley; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2013-11-16       Impact factor: 3.641

8.  Novel epitopic region of glucosyltransferase B from Streptococcus mutans.

Authors:  Tomonori Hoshino; Yoshio Kondo; Kan Saito; Yutaka Terao; Nobuo Okahashi; Shigetada Kawabata; Taku Fujiwara
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

9.  Comparative analysis of Gtf isozyme production and diversity in isolates of Streptococcus mutans with different biofilm growth phenotypes.

Authors:  Renata O Mattos-Graner; Marcelo H Napimoga; Kasuo Fukushima; Margaret J Duncan; Daniel J Smith
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.